Indonesian genotech firm Nusantics secures funding for new Covid-19 test kit tech

Nusantics is planning to use the fund to continue expanding its research and development in the field of genomes of different microorganisms. Aside from microbiome analysis, Nusantics also plans to delve into research and production geared towards medical diagnostic kits, specifically Covid-19.